Data Insights

Q4 2023 update: mentions of COVID-19 in pharmaceutical industry filings

The global pharmaceutical industry experienced a 69% drop in company filings mentions of COVID-19 in Q4 2023 compared with the...

Pharma: Filings Trends & Signals Q2 2024

Data Insights

Q4 2023 update: COVID-19 related M&A activity in the pharmaceutical industry

Analysis of the key themes driving M&A activity reveals that COVID-19 accounted for 2 pharmaceutical deals announced in Q4 2023,...

Pharma M&A Deals 2023 - Top Themes - Thematic Intelligence

Data Insights

Q3 2023 update: COVID-19 related M&A activity in the pharmaceutical industry

Analysis of the key themes driving M&A activity reveals that COVID-19 accounted for 2 pharmaceutical deals announced in Q3 2023,...

Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q2 2023 - Thematic Intelligence

Data Insights

Q3 2023 update: mentions of COVID-19 in pharmaceutical industry filings

The global pharmaceutical industry experienced a 73% drop in company filings mentions of COVID-19 in Q3 2023 compared with the...

Pharma: Filings Trends & Signals Q3 2023